midodrine and pentoxifylline

midodrine has been researched along with pentoxifylline in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Behm, BW; Caldwell, SH; Cornella, SL; Henry, Z; Northup, PG; Shah, NL; Stine, JG; Wang, J1

Reviews

1 review(s) available for midodrine and pentoxifylline

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for midodrine and pentoxifylline

ArticleYear
Treatment of Type-1 Hepatorenal Syndrome with Pentoxifylline: A Randomized Placebo Controlled Clinical Trial.
    Annals of hepatology, 2018, Mar-01, Volume: 17, Issue:2

    Topics: Aged; Albumins; Drug Therapy, Combination; Female; Hepatorenal Syndrome; Hospital Mortality; Humans; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Midodrine; Octreotide; Patient Admission; Pentoxifylline; Pilot Projects; Time Factors; Treatment Outcome; Vasoconstrictor Agents; Virginia

2018

Other Studies

1 other study(ies) available for midodrine and pentoxifylline

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004